Literature DB >> 32892421

Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice.

Maria Manti1, Han-Pin Pui1,2, Sonja Edström1, Sanjiv Risal1, Haojiang Lu1, Eva Lindgren1, Claes Ohlsson3, Elisabet Jerlhag4, Anna Benrick5,6, Qiaolin Deng1,2, Elisabet Stener-Victorin1.   

Abstract

Nerve growth factor (NGF) is critical for the development and maintenance of the peripheral sympathetic neurons. NGF is also involved in the ovarian sympathetic innervation and in the development and maintenance of folliculogenesis. Women with the endocrine disorder, polycystic ovary syndrome (PCOS), have an increased sympathetic nerve activity and increased ovarian NGF levels. The role of ovarian NGF excess in the PCOS pathophysiology and in the PCOS-related features is unclear. Here, using transgenic mice overexpressesing NGF in the ovarian theca cells (17NF mice), we assessed the female embryonic development, and the reproductive and metabolic profile in adult females. Ovarian NGF excess caused growth restriction in the female fetuses, and a delayed gonocyte and primary oocyte maturation. In adulthood, the 17NF mice displayed irregular estrous cycles and altered ovarian expression of steroidogenic and epigenetic markers. They also exhibited an increased sympathetic output with increased circulating dopamine, and metabolic dysfunction reflected by aberrant adipose tissue morphology and function, impaired glucose metabolism, decreased energy expenditure, and hepatic steatosis. These findings indicate that ovarian NGF excess leads to adverse fetal development and to reproductive and metabolic complications in adulthood, mirroring common features of PCOS. This work provides evidence that NGF excess may be implicated in the PCOS pathophysiology.
© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  adipose tissue; imprinting; polycystic ovary syndrome; sex steroids; sympathetic activity

Year:  2020        PMID: 32892421     DOI: 10.1096/fj.202001060R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  3 in total

1.  Nerve Growth Factor: A Dual Activator of Noradrenergic and Cholinergic Systems of the Rat Ovary.

Authors:  Agustin Benitez; Raul Riquelme; Miguel Del Campo; Camila Araya; Hernan E Lara
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

Review 2.  Effect of Acupuncture on Polycystic Ovary Syndrome in Animal Models: A Systematic Review.

Authors:  Yan Li; Lijia Zhang; Jinjin Gao; Jun Yan; Xue Feng; Xiting He; Hong Jin; Xinyu Li; Zhengyi Cui; Junfei Zhao; Fengyi Liu; Xiaowai Liu; Yongfei Liu; Wan Ren; Songjiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-24       Impact factor: 2.629

3.  Moderate Aerobic Exercise Regulates Follicular Dysfunction by Initiating Brain-Derived Neurotrophic Factor (BDNF)-Mediated Anti-Apoptotic Signaling Pathways in Polycystic Ovary Syndrome.

Authors:  Yaling Zhang; Dejian Chen; Daojuan Wang; Lei Wang; Yajing Weng; Hongwei Wang; Xiaoke Wu; Yong Wang
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.